Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination therapy with adalimumab plus intensive granulocyte and monocyte adsorptive apheresis induced clinical remission in a Crohn's disease patient with the loss of response to scheduled adalimumab maintenance therapy: a case report.
Ozeki K, Tanida S, Mizushima T, Mizoshita T, Tsukamoto H, Hirata Y, Murakami K, Shimura T, Kataoka H, Kamiya T, Joh T. Ozeki K, et al. Among authors: tanida s. Intern Med. 2012;51(6):595-9. doi: 10.2169/internalmedicine.51.6801. Epub 2012 Mar 15. Intern Med. 2012. PMID: 22449667 Free article.
Helicobacter pylori eradication decreases blood neutrophil and monocyte counts.
Kondo Y, Joh T, Sasaki M, Oshima T, Itoh K, Tanida S, Kataoka H, Ohara H, Nomura T, Itoh M. Kondo Y, et al. Among authors: tanida s. Aliment Pharmacol Ther. 2004 Jul;20 Suppl 1:74-9. doi: 10.1111/j.1365-2036.2004.01988.x. Aliment Pharmacol Ther. 2004. PMID: 15298609 Clinical Trial.
Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
Wada T, Sasaki M, Kataoka H, Tanida S, Itoh K, Ogasawara N, Oshima T, Togawa S, Kubota E, Yamada T, Mori Y, Fujita F, Ohara H, Nakao H, Sobue S, Joh T, Itoh M. Wada T, et al. Among authors: tanida s. Aliment Pharmacol Ther. 2005 Jun;21 Suppl 2:2-9. doi: 10.1111/j.1365-2036.2005.02467.x. Aliment Pharmacol Ther. 2005. PMID: 15943840 Clinical Trial.
Oral vaccination against Helicobacter pylori with recombinant cholera toxin B-subunit.
Kubota E, Joh T, Tanida S, Sasaki M, Kataoka H, Watanabe K, Itoh K, Oshima T, Ogasawara N, Togawa S, Wada T, Yamada T, Mori Y, Fujita F, Shimura T, Ohara H, Isaka M, Yasuda Y, Itoh M. Kubota E, et al. Among authors: tanida s. Helicobacter. 2005 Aug;10(4):345-52. doi: 10.1111/j.1523-5378.2005.00328.x. Helicobacter. 2005. PMID: 16104951
Helicobacter pylori eradication decreases the expression of glycosylphosphatidylinositol-anchored complement regulators, decay-accelerating factor and homologous restriction factor 20, in human gastric epithelium.
Joh T, Sasaki M, Kataoka H, Tanida S, Itoh K, Kondo Y, Ogasawara N, Oshima T, Okada N, Ohara H, Sano H, Nakao H, Sobue S, Itoh M. Joh T, et al. Among authors: tanida s. J Gastroenterol Hepatol. 2005 Sep;20(9):1344-51. doi: 10.1111/j.1440-1746.2005.03876.x. J Gastroenterol Hepatol. 2005. PMID: 16105119
234 results